Allostery and Biased Agonism at Class B G Protein-Coupled Receptors
The DOI matches its Crossref record; 281 of the 281 references it cites were found in a registry or an index.
Abstract
Class B G protein-coupled receptors (GPCRs) respond to paracrine or endocrine peptide hormones involved in control of bone homeostasis, glucose regulation, satiety, and gastro-intestinal function, as well as pain transmission. These receptors are targets for existing drugs that treat osteoporosis, hypercalcaemia, Paget's disease, type II diabetes, and obesity and are being actively pursued as targets for numerous other diseases. Exploitation of class B receptors has been limited by difficulties with small molecule drug discovery and development and an under appreciation of factors governing optimal therapeutic efficacy. Recently, there has been increasing awareness of novel attributes of GPCR function that offer new opportunity for drug development. These include the presence of allosteric binding sites on the receptor that can be exploited as drug binding pockets and the ability of individual drugs to enrich subpopulations of receptor conformations to selectively control signaling, a phenomenon termed biased agonism. In this review, current knowledge of biased signaling and small molecule allostery within class B GPCRs is discussed, highlighting areas that have progressed significantly over the past decade, in addition to those that remain largely unexplored with respect to these phenomena.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As far as GIP is concerned, after binding its receptor on beta cells, GIP transduces its biological effects by increasing in cAMP and intracytoplasmic Ca2+ levels, in addition to the activation of PI3K, AKT, PKA, p38 MAP kinases and phospholipase A2 [41].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [41]
Citations
Cites
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
Kunishima, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Jingami, H., & Morikawa, K. (2000) · Nature · doi:10.1038/35039564 · Cited by 1,249
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
Vaudry, D., Falluel-Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., Fournier, A., Chow, B. K. C., Hashimoto, H., Galas, L., et al. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001370 · Cited by 1,058
Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925
Lovenberg, T. W., Liaw, C. W., Grigoriadis, D. E., Clevenger, W., Chalmers, D. T., De Souza, E. B., & Oltersdorf, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.836 · Cited by 846
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
Self-citationSignalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Self-citationUnimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Self-citationNeubig, R. R., Spedding, M., Kenakin, T., & Christopoulos, A. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.4 · Cited by 665
Self-citationHsu, S. Y., & Hsueh, A. J. W. (2001) · Nature Medicine · doi:10.1038/87936 · Cited by 650
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Finan, B., Yang, B., Ottaway, N., Smiley, D. L., Ma, T., Clemmensen, C., Chabenne, J., Zhang, L., Habegger, K. M., Fischer, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3761 · Cited by 645
Nobles, K. N., Xiao, K., Ahn, S., Shukla, A. K., Lam, C. M., Rajagopal, S., Strachan, R. T., Huang, T.-Y., Bressler, E. A., Hara, M. R., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001707 · Cited by 626
Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
Self-citationSustained cyclic AMP production by parathyroid hormone receptor endocytosis
Ferrandon, S., Feinstein, T. N., Castro, M., Wang, B., Bouley, R., Potts, J. T., Gardella, T. J., & Vilardaga, J.-P. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.206 · Cited by 572
G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Ferré, S., Casadó, V., Devi, L. A., Filizola, M., Jockers, R., Lohse, M. J., Milligan, G., Pin, J.-P., & Guitart, X. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008052 · Cited by 570
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Mayo, K. E., Miller, L. J., Bataille, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 506
Self-citationEmerging paradigms in GPCR allostery: implications for drug discovery
Wootten, D., Christopoulos, A., & Sexton, P. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4052 · Cited by 498
Self-citationChristopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Self-citationA Simple Method for Quantifying Functional Selectivity and Agonist Bias
Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A., & Novick, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200111m · Cited by 484
Self-citationGesty-Palmer, D., Chen, M., Reiter, E., Ahn, S., Nelson, C. D., Wang, S., Eckhardt, A. E., Cowan, C. L., Spurney, R. F., Luttrell, L. M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513380200 · Cited by 476
Harmar, A. J., Fahrenkrug, J., Gozes, I., Laburthe, M., May, V., Pisegna, J. R., Vaudry, D., Vaudry, H., Waschek, J. A., & Said, S. I. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01871.x · Cited by 471
Jeppesen, P. B. (2005) · Gut · doi:10.1136/gut.2004.061440 · Cited by 469
Structure of class B GPCR corticotropin-releasing factor receptor 1
Hollenstein, K., Kean, J., Bortolato, A., Cheng, R. K. Y., Doré, A. S., Jazayeri, A., Cooke, R. M., Weir, M., & Marshall, F. H. (2013) · Nature · doi:10.1038/nature12357 · Cited by 416
Molecular cloning and expression of a cDNA encoding the secretin receptor.
Ishihara, T., Nakamura, S., Kaziro, Y., Takahashi, T., Takahashi, K., & Nagata, S. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07686.x · Cited by 407
The metabolic actions of glucagon revisited
Habegger, K. M., Heppner, K. M., Geary, N., Bartness, T. J., DiMarchi, R., & Tschöp, M. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.187 · Cited by 406
Bangasser, D. A., Curtis, A., Reyes, B. A. S., Bethea, T. T., Parastatidis, I., Ischiropoulos, H., Van Bockstaele, E. J., & Valentino, R. J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.66 · Cited by 401
Activation of two signal-transduction systems in hepatocytes by glucagon
Wakelam, M. J. O., Murphy, G. J., Hruby, V. J., & Houslay, M. D. (1986) · Nature · doi:10.1038/323068a0 · Cited by 388
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Rajagopal, S., Ahn, S., Rominger, D. H., Gowen-MacDonald, W., Lam, C. M., DeWire, S. M., Violin, J. D., & Lefkowitz, R. J. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072801 · Cited by 388
Structure of the human glucagon class B G-protein-coupled receptor
Siu, F. Y., He, M., de Graaf, C., Han, G. W., Yang, D., Zhang, Z., Zhou, C., Xu, Q., Wacker, D., Joseph, J. S., et al. (2013) · Nature · doi:10.1038/nature12393 · Cited by 379
Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors
Hoare, S. R. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03370-2 · Cited by 379
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology
Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.004 · Cited by 363
Self-citationInterhelical hydrogen bonding drives strong interactions in membrane proteins.
Engelman, D. M., Zhou, F. X., Cocco, M. J., Russ, W. P., & Brünger, A. T. (2000) · Nature Structural Biology · doi:10.1038/72430 · Cited by 349
Evans, B. N., Rosenblatt, M. I., Mnayer, L. O., Oliver, K. R., & Dickerson, I. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005604200 · Cited by 337
Fujino, T., Asaba, H., Kang, M.-J., Ikeda, Y., Sone, H., Takada, S., Kim, D.-H., Ioka, R. X., Ono, M., Tomoyori, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0133792100 · Cited by 336
Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2
Munroe, D. G., Gupta, A. K., Kooshesh, F., Vyas, T. B., Rizkalla, G., Wang, H., Demchyshyn, L., Yang, Z.-J., Kamboj, R. K., Chen, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1569 · Cited by 328
The role of kinetic context in apparent biased agonism at GPCRs
Klein Herenbrink, C., Sykes, D. A., Donthamsetti, P., Canals, M., Coudrat, T., Shonberg, J., Scammells, P. J., Capuano, B., Sexton, P. M., Charlton, S. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10842 · Cited by 328
Self-citationNovel Receptor Partners and Function of Receptor Activity-modifying Proteins
Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., & Sexton, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200629200 · Cited by 309
Self-citationTobin, A. B., Butcher, A. J., & Kong, K. C. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.006 · Cited by 308
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors
SLOMINSKI, A., WORTSMAN, J., PISARCHIK, A., ZBYTEK, B., LINTON, E. A., MAZURKIEWICZ, J. E., & WEI, E. T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0850rev · Cited by 305
Underwood, C. R., Garibay, P., Knudsen, L. B., Hastrup, S., Peters, G. H., Rudolph, R., & Reedtz-Runge, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033829 · Cited by 295
Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain
Runge, S., Thøgersen, H., Madsen, K., Lau, J., & Rudolph, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708740200 · Cited by 291
Biased agonism: An emerging paradigm in GPCR drug discovery
Rankovic, Z., Brust, T. F., & Bohn, L. M. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.024 · Cited by 282
Islet α cells and glucagon--critical regulators of energy homeostasis
Campbell, J. E., & Drucker, D. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.51 · Cited by 266
Allosteric modulation of G protein-coupled receptors: A pharmacological perspective
Keov, P., Sexton, P. M., & Christopoulos, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.010 · Cited by 265
Self-citationPTH receptor-1 signalling—mechanistic insights and therapeutic prospects
Cheloha, R. W., Gellman, S. H., Vilardaga, J.-P., & Gardella, T. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.139 · Cited by 265
Wootten, D., Simms, J., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221585110 · Cited by 250
Self-citationMolecular recognition of parathyroid hormone by its G protein-coupled receptor
Pioszak, A. A., & Xu, H. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801027105 · Cited by 241
Hay, D. L., Poyner, D. R., & Sexton, P. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.015 · Cited by 239
Self-citationMcClean, P. L., Irwin, N., Cassidy, R. S., Holst, J. J., Gault, V. A., & Flatt, P. R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00460.2007 · Cited by 239
Insights into the structure of class B GPCRs
Hollenstein, K., de Graaf, C., Bortolato, A., Wang, M.-W., Marshall, F. H., & Stevens, R. C. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.11.001 · Cited by 239
Christopoulos, A., Changeux, J.-P., Catterall, W. A., Fabbro, D., Burris, T. P., Cidlowski, J. A., Olsen, R. W., Peters, J. A., Neubig, R. R., Pin, J.-P., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.008862 · Cited by 238
Self-citationAngel, T. E., Chance, M. R., & Palczewski, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903545106 · Cited by 235
Biased signalling and allosteric machines: new vistas and challenges for drug discovery
Kenakin, T. P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01749.x · Cited by 233
Small-molecule agonists for the glucagon-like peptide 1 receptor
Knudsen, L. B., Kiel, D., Teng, M., Behrens, C., Bhumralkar, D., Kodra, J. T., Holst, J. J., Jeppesen, C. B., Johnson, M. D., de Jong, J. C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605701104 · Cited by 232
Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor
Parthier, C., Kleinschmidt, M., Neumann, P., Rudolph, R., Manhart, S., Schlenzig, D., Fanghänel, J., Rahfeld, J.-U., Demuth, H.-U., & Stubbs, M. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706404104 · Cited by 232
Parathyroid hormone signaling through low-density lipoprotein-related protein 6
Wan, M., Yang, C., Li, J., Wu, X., Yuan, H., Ma, H., He, X., Nie, S., Chang, C., & Cao, X. (2008) · Genes & Development · doi:10.1101/gad.1702708 · Cited by 231
Pantaloni, C., Brabet, P., Bilanges, B., Dumuis, A., Houssami, S., Spengler, D., Bockaert, J., & Journot, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22146 · Cited by 223
Koole, C., Wootten, D., Simms, J., Valant, C., Sridhar, R., Woodman, O. L., Miller, L. J., Summers, R. J., Christopoulos, A., & Sexton, P. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065664 · Cited by 223
Self-citationAdvances in G Protein-Coupled Receptor Allostery: From Function to Structure
Christopoulos, A. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094342 · Cited by 220
Self-citationSequence motifs, polar interactions and conformational changes in helical membrane proteins
Curran, A. R., & Engelman, D. M. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00102-7 · Cited by 219
Familial Dwarfism due to a Novel Mutation of the Growth Hormone-Releasing Hormone Receptor Gene1
Salvatori, R., Hayashida, C. Y., Aguiar-Oliveira, M. H., Phillips, J. A., Souza, A. H. O., Gondo, R. G., Toledo, S. P. A., Conceicão, M. M., Prince, M., Maheshwari, H. G., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5599 · Cited by 218
Gorn, A. H., Lin, H. Y., Yamin, M., Auron, P. E., Flannery, M. R., Tapp, D. R., Manning, C. A., Lodish, H. F., Krane, S. M., & Goldring, S. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116046 · Cited by 211
Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., & Luttrell, L. M. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000071 · Cited by 205
Moro, O., & Lerner, E. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.966 · Cited by 202
Neermann, J., & Wagner, R. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199601)166:1<152::aid-jcp18>3.0.co;2-h · Cited by 202
The nacre protein perlucin nucleates growth of calcium carbonate crystals
Blank, S., Arnoldi, M., Khoshnavaz, S., Treccani, L., Kuntz, M., Mann, K., Grathwohl, G., & Fritz, M. (2003) · Journal of Microscopy · doi:10.1111/j.1365-2818.2003.01263.x · Cited by 201
Novel Allosteric Modulators of G Protein-coupled Receptors
Gentry, P. R., Sexton, P. M., & Christopoulos, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.662759 · Cited by 199
Self-citationGrace, C. R. R., Perrin, M. H., DiGruccio, M. R., Miller, C. L., Rivier, J. E., Vale, W. W., & Riek, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404702101 · Cited by 193
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Hay, D. L., & Pioszak, A. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103120 · Cited by 190
Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
Luttrell, L. M., Maudsley, S., & Bohn, L. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099630 · Cited by 190
ter Haar, E., Koth, C. M., Abdul-Manan, N., Swenson, L., Coll, J. T., Lippke, J. A., Lepre, C. A., Garcia-Guzman, M., & Moore, J. M. (2010) · Structure · doi:10.1016/j.str.2010.05.014 · Cited by 189
Pisegna, J. R., & Wank, S. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17267 · Cited by 185
Differential Expression of a Cutaneous Corticotropin-Releasing Hormone System
Slominski, A., Pisarchik, A., Tobin, D. J., Mazurkiewicz, J. E., & Wortsman, J. (2004) · Endocrinology · doi:10.1210/en.2003-0851 · Cited by 180
Rickard, D. J., Wang, F., Rodriguez-Rojas, A.-M., Wu, Z., Trice, W. J., Hoffman, S. J., Votta, B. J., Stroup, G. B., Kumar, S., & NUTTALL, M. E. (2006) · Bone · doi:10.1016/j.bone.2006.06.010 · Cited by 170
A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db / db mice
Chen, D., Liao, J., Li, N., Zhou, C., Liu, Q., Wang, G., Zhang, R., Zhang, S., Lin, L., Chen, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610173104 · Cited by 169
Nicole, P., Lins, L., Rouyer-Fessard, C., Drouot, C., Fulcrand, P., Thomas, A., Couvineau, A., Martinez, J., Brasseur, R., & Laburthe, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002325200 · Cited by 168
Okazaki, M., Ferrandon, S., Vilardaga, J.-P., Bouxsein, M. L., Potts, J. T., & Gardella, T. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808750105 · Cited by 167
Regulation of signal transduction by calcitonin gene-related peptide receptors
Walker, C. S., Conner, A. C., Poyner, D. R., & Hay, D. L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.06.006 · Cited by 166
Sexton, P. M., Findlay, D. M., & Martin, T. J. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730611220401164504 · Cited by 163
Self-citationO'Callaghan, K., Kuliopulos, A., & Covic, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.355461 · Cited by 157
Real-time trafficking and signaling of the glucagon-like peptide-1 receptor
Roed, S. N., Wismann, P., Underwood, C. R., Kulahin, N., Iversen, H., Cappelen, K. A., Schäffer, L., Lehtonen, J., Hecksher-Soerensen, J., Secher, A., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.010 · Cited by 153
Gourlet, P., Vertongen, P., Vandermeers, A., Vandermeers‐Piret, M., Rathé, J., NEEF, P. D., Waelbroeck, M., & Robberecht, P. (1997) · Peptides · doi:10.1016/s0196-9781(96)00322-1 · Cited by 151
Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1
Pioszak, A. A., Parker, N. R., Suino-Powell, K., & Xu, H. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805749200 · Cited by 150
Kuna, R. S., Girada, S. B., Asalla, S., Vallentyne, J., Maddika, S., Patterson, J. T., Smiley, D. L., DiMarchi, R. D., & Mitra, P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00551.2012 · Cited by 150
Cloning and characterization of an abundant subtype of the human calcitonin receptor.
Kuestner, R. E., Elrod, R. D., Grant, F. J., Hagen, F. S., Kuijper, J. L., Matthewes, S. L., O'Hara, P. J., Sheppard, P. O., Stroop, S. D., & Thompson, D. L. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09678-6 · Cited by 149
Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women
Cosman, F., Lane, N. E., Bolognese, M. A., Zanchetta, J. R., Garcia-Hernandez, P. A., Sees, K., Matriano, J. A., Gaumer, K., & Daddona, P. E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0358 · Cited by 148
Pioszak, A. A., Parker, N. R., Gardella, T. J., & Xu, H. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022905 · Cited by 147
The pharmacology of Adrenomedullin 2/Intermedin
Hong, Y., Hay, D. L., Quirion, R., & Poyner, D. R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01530.x · Cited by 144
Gault, V. A., O'Harte, F. P. M., Harriott, P., Mooney, M., Green, B., & Flatt, P. R. (2003) · Diabetologia · doi:10.1007/s00125-002-1028-x · Cited by 141
Goltzmann, D., PEYTREMANN, A., Callahan, E. N., Tregear, G., & Potts, J. T. J. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41611-6 · Cited by 140
Sun, C. C., Song, D., Davis‐Taber, R., Barrett, L. W., Scott, V., Richardson, P. L., Pereda‐Lopez, A., Uchic, M. E., Solomon, L. R., Lake, M. R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611397104 · Cited by 138
Jørgensen, R., Kubale, V., Vrecl, M., Schwartz, T. W., & Elling, C. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120006 · Cited by 138
Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects
Zhang, H., Sturchler, E., Zhu, J., Nieto, A., Cistrone, P. A., Xie, J., He, L., Yea, K., Jones, T., Turn, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms9918 · Cited by 137
Morfis, M., Tilakaratne, N., Furness, S. G. B., Christopoulos, G., Werry, T. D., Christopoulos, A., & Sexton, P. M. (2008) · Endocrinology · doi:10.1210/en.2007-1735 · Cited by 134
Self-citationHorwitz, M. J., Tedesco, M. B., Sereika, S. M., Hollis, B. W., Garcia-Ocaña, A., & Stewart, A. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020773 · Cited by 130
Grace, C. R. R., Perrin, M. H., Gulyas, J., DiGruccio, M. R., Cantle, J. P., Rivier, J. E., Vale, W. W., & Riek, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700682104 · Cited by 130
Yusta, B., Boushey, R. P., & Drucker, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005510200 · Cited by 127
Tsutsumi, M., Claus, T. H., Liang, Y., Li, Y., Yang, L., Zhu, J., Dela Cruz, F., Peng, X., Chen, H., Yung, S. L., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1453 · Cited by 126
Valant, C., May, L. T., Aurelio, L., Chuo, C. H., White, P. J., Baltos, J., Sexton, P. M., Scammells, P. J., & Christopoulos, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320962111 · Cited by 125
Self-citationMolecular basis for negative regulation of the glucagon receptor
Koth, C. M., Murray, J. M., Mukund, S., Madjidi, A., Minn, A., Clarke, H. J., Wong, T., Chiang, V., Luis, E., Estevez, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206734109 · Cited by 125
Grammatopoulos, D. K., Dai, Y., Randeva, H., Levine, M. A., Karteris, E., Easton, A. J., & Hillhouse, E. W. (1999) · Molecular Endocrinology · doi:10.1210/me.13.12.2189 · Cited by 124
Booe, J. M., Walker, C. S., Barwell, J., Kuteyi, G., Simms, J., Jamaluddin, M. A., Warner, M. L., Bill, R. M., Harris, P. W., Brimble, M. A., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.018 · Cited by 122
VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins
Couvineau, A., & Laburthe, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01676.x · Cited by 122
Gardella, T. J., & Vilardaga, J. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009464 · Cited by 119
Structure of Class B GPCRs: new horizons for drug discovery
Bortolato, A., Doré, A. S., Hollenstein, K., Tehan, B. G., Mason, J. S., & Marshall, F. H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12689 · Cited by 117
Salvatori, R., Fan, X., Phillips, J. A., Martín, R. E., de Lara, I. M., Freeman, K. L., Plotnick, L., Al-Ashwal, A. A., & Levine, M. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7156 · Cited by 117
A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor
Valdenaire, O., Giller, T., Breu, V., Gottowik, J., & Kilpatrick, G. J. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00047-x · Cited by 115
Méry, P., Brechler, V., Pavoine, C., Pecker, F., & Fischmeister, R. (1990) · Nature · doi:10.1038/345158a0 · Cited by 113
Molecular Pharmacology of the Calcitonin Receptor
Purdue, B. W., Tilakaratne, N., & Sexton, P. M. (2002) · Receptors and Channels · doi:10.1080/10606820213681 · Cited by 113
Self-citationKoole, C., Wootten, D. L., Simms, J., Valant, C., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072884 · Cited by 113
Self-citationGault, V. A., O'Harte, F. P. M., Harriott, P., & Flatt, P. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6364 · Cited by 108
A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness
Beinborn, M., Worrall, C. I., McBride, E. W., & Kopin, A. S. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.05.001 · Cited by 107
On the analysis of ligand-directed signaling at G protein-coupled receptors
Ehlert, F. J. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0260-4 · Cited by 106
Review article: a comparison of glucagon‐like peptides 1 and 2
Janssen, P., Rotondo, A., Mulé, F., & Tack, J. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12092 · Cited by 105
Yusta, B., Somwar, R., Wang, F., Munroe, D., Grinstein, S., Klip, A., & Drucker, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30459 · Cited by 103
Watson, C., Chen, G., Irving, P. E., Way, J. M., Chen, W.-J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1230 · Cited by 103
Blechman, J., & Levkowitz, G. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00055 · Cited by 102
Harikumar, K. G., Pinon, D. I., & Miller, L. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702325200 · Cited by 102
Self-citationWidenmaier, S. B., Kim, S.-J., Yang, G. K., De Los Reyes, T., Nian, C., Asadi, A., Seino, Y., Kieffer, T. J., Kwok, Y. N., & McIntosh, C. H. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009590 · Cited by 102
Lutz, E. M., Ronaldson, E., Shaw, P. D., Johnson, M. S., Holland, P. J., & Mitchell, R. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.09.008 · Cited by 100
Taboulet, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2129 · Cited by 100
Shonberg, J., Lopez, L., Scammells, P. J., Christopoulos, A., Capuano, B., & Lane, J. R. (2014) · Medicinal Research Reviews · doi:10.1002/med.21318 · Cited by 98
Self-citationEndosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase
Gidon, A., Al‐bataineh, M. M., Jean‐Alphonse, F., Stevenson, H. P., Watanabe, T., Louet, C., Khatri, A., Calero, G. A., Pastor‐Soler, N. M., Gardella, T. J., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1589 · Cited by 98
Yusta, B., Estall, J. L., & Drucker, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201358200 · Cited by 98
A Potent α/β-Peptide Analogue of GLP-1 with Prolonged Action in Vivo
Johnson, L. M., Barrick, S., Hager, M. V., McFedries, A., Homan, E. A., Rabaglia, M. E., Keller, M. P., Attie, A. D., Saghatelian, A., Bisello, A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja507168t · Cited by 96
Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs
Lee, S. M., Booe, J. M., & Pioszak, A. A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.013 · Cited by 92
Romero, G., Sneddon, W. B., Yang, Y., Wheeler, D., Blair, H. C., & Friedman, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102970 · Cited by 91
Wootten, D. L., Savage, E. E., Willard, F. S., Bueno, A. B., Sloop, K. W., Christopoulos, A., & Sexton, P. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084525 · Cited by 91
Self-citationWootten, D. L., Simms, J., Koole, C., Woodman, O. L., Summers, R. J., Christopoulos, A., & Sexton, P. M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.176362 · Cited by 90
Self-citationThe truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist
Thulesen, J., Knudsen, L. B., Hartmann, B., Hastrup, S., Kissow, H., Jeppesen, P. B., Ørskov, C., Holst, J. J., & Poulsen, S. S. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00316-0 · Cited by 90
Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias
Andreassen, K. V., Hjuler, S. T., Furness, S. G., Sexton, P. M., Christopoulos, A., Nosjean, O., Karsdal, M. A., & Henriksen, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092042 · Cited by 89
Self-citationSecretin: structure of the precursor and tissue distribution of the mRNA.
Kopin, A. S., Wheeler, M. B., & Leiter, A. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2299 · Cited by 89
Koole, C., Wootten, D., Simms, J., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309328 · Cited by 87
Self-citationRavn, P., Madhurantakam, C., Kunze, S., Matthews, E., Priest, C., O'Brien, S., Collinson, A., Papworth, M., Fritsch-Fredin, M., Jermutus, L., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426288 · Cited by 86
Busto, R., Schally, A. V., Varga, J. L., Garcia-Fernandez, M. O., Groot, K., Armatis, P. E., & Szepesházi, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182433099 · Cited by 86
A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification
Nolte, W. M., Fortin, J.-P., Stevens, B. D., Aspnes, G. E., Griffith, D. A., Hoth, L. R., Ruggeri, R. B., Mathiowetz, A. M., Limberakis, C., Hepworth, D., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1581 · Cited by 86
A Novel Method for Analyzing Extremely Biased Agonism at G Protein–Coupled Receptors
Stahl, E. L., Zhou, L., Ehlert, F. J., & Bohn, L. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096503 · Cited by 86
Schelshorn, D. W., Joly, F., Mutel, S., Hampe, C., Breton, B., Mutel, V., & Lütjens, R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074757 · Cited by 86
Pabreja, K., Mohd, M. A., Koole, C., Wootten, D., & Furness, S. G. B. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12313 · Cited by 84
Self-citationWootten, D., Lindmark, H., Kadmiel, M., Willcockson, H., Caron, K., Barwell, J., Drmota, T., & Poyner, D. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02202.x · Cited by 83
Self-citationCai, R., Schally, A. V., Cui, T., Szalontay, L., Halmos, G., Sha, W., Kovács, M., Jászberényi, M., He, J., Rick, F. G., et al. (2013) · Peptides · doi:10.1016/j.peptides.2013.12.010 · Cited by 83
Thompson, A., & Kanamarlapudi, V. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.10.015 · Cited by 82
Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor
Willard, F. S., Bueno, A. B., & Sloop, K. W. (2012) · Experimental Diabetes Research · doi:10.1155/2012/709893 · Cited by 81
Modulating receptor function through RAMPs: can they represent drug targets in themselves?
Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.009 · Cited by 81
Self-citationArchbold, J. K., Flanagan, J. U., Watkins, H. A., Gingell, J. J., & Hay, D. L. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.007 · Cited by 80
Solano, R. M., Langer, I., Perret, J., Vertongen, P., Juarranz, M. G., Robberecht, P., & Waelbroeck, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007696200 · Cited by 80
Bench-to-bedside pharmacology of adrenomedullin
Kato, J., & Kitamura, K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.061 · Cited by 79
Leen, J., Izzo, A. A., Upadhyay, C., Rowland, K., Dubé, P. E., Gu, S., Heximer, S. P., Rhodes, C. J., Storm, D. R., Lund, P. K., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0822 · Cited by 79
Role of Receptor Phosphorylation in Desensitization and Internalization of the Secretin Receptor
Holtmann, M. H., Roettger, B. F., Pinon, D. I., & Miller, L. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23566 · Cited by 79
Self-citationTibaduiza, E. C., Chen, C., & Beinborn, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106692200 · Cited by 78
Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery
Wootten, D. L., Savage, E. E., Valant, C., May, L. T., Sloop, K. W., FICORILLI, J. V., Showalter, A. D., Willard, F. S., Christopoulos, A., & Sexton, P. M. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.079319 · Cited by 78
Self-citationStructural Basis for Hormone Recognition by the Human CRFR2α G Protein-coupled Receptor
Pal, K., Swaminathan, K., Xu, H. E., & Pioszak, A. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186072 · Cited by 77
Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)
Weston, C., Lu, J., Li, N., Barkan, K., Richards, G. O., Roberts, D. J., Skerry, T. M., Poyner, D., Pardamwar, M., Reynolds, C. A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624601 · Cited by 77
Adenyl Cyclase and Myocardial Contractility
Epstein, S. E., Skelton, C. L., Levey, G. S., & Entman, M. L. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-4-561 · Cited by 75
Navarro, G., Quiroz, C., Moreno-Delgado, D., Sierakowiak, A., McDowell, K., Moreno, E., Rea, W., Cai, N.-S., Aguinaga, D., Howell, L. A., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4364-14.2015 · Cited by 75
Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function
Koole, C., Pabreja, K., Savage, E. E., Wootten, D., Furness, S. G. B., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120236 · Cited by 75
Self-citationEleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic Activity
Mapelli, C., Natarajan, S. I., Meyer, J.-P., Bastos, M. M., Bernatowicz, M. S., Lee, V. G., Pluscec, J., Riexinger, D. J., Sieber-McMaster, E. S., Constantine, K. L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900752a · Cited by 74
Kiaris, H., Chatzistamou, I., Schally, A. V., Halmos, G., Varga, J. L., Koutselini, H., & Kalofoutis, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533185100 · Cited by 74
Kahán, Z., Kahán, Z., Varga, J. L., Varga, J. L., Schally, A. V., Schally, A. V., Rékási, Z., Rékási, Z., Armatis, P. E., Chatzistamou, I., et al. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006363230990 · Cited by 74
Harikumar, K. G., Wootten, D., Pinon, D. I., Koole, C., Ball, A. M., Furness, S. G. B., Graham, B., Dong, M., Christopoulos, A., Miller, L. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205227109 · Cited by 73
Self-citationde Graaf, C., Rein, C., Piwnica, D., Giordanetto, F., & Rognan, D. (2011) · ChemMedChem · doi:10.1002/cmdc.201100317 · Cited by 72
Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors
Culhane, K. J., Liu, Y., Cai, Y., & Yan, E. C. Y. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00264 · Cited by 72
Gelling, R. W., Coy, D. H., Pederson, R. A., Wheeler, M. B., Hinke, S. A., Kwan, T., & McIntosh, C. H. S. (1997) · Regulatory Peptides · doi:10.1016/s0167-0115(97)00009-8 · Cited by 71
Wootten, D. L., Reynolds, C. A., Koole, C., Smith, K. J., Mobarec, J. C., Simms, J., Quon, T., Coudrat, T., Furness, S. G. B., Miller, L. J., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.101246 · Cited by 71
Self-citationHilton, J., Dowton, M., Houssami, S., & Sexton, P. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660213 · Cited by 70
Self-citationCupp, M. E., Nayak, S. K., Adem, A. S., & Thomsen, W. J. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.199752 · Cited by 70
Ali, S., Ussher, J. R., Baggio, L. L., Kabir, M. G., Charron, M. J., Ilkayeva, O., Newgard, C. B., & Drucker, D. J. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.11.005 · Cited by 69
Harikumar, K. G., Morfis, M. M., Lisenbee, C. S., Sexton, P. M., & Miller, L. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015776 · Cited by 67
Self-citationChatzistamou, I., Schally, A. V., Varga, J. L., Groot, K., Busto, R., Armatis, P. E., & Halmos, G. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200110000-00008 · Cited by 66
Udawela, M., Christopoulos, G., Tilakaratne, N., Christopoulos, A., Albiston, A. L., & Sexton, P. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021915 · Cited by 66
Self-citationAllostery in GPCRs: ‘MWC’ revisited
Canals, M., Sexton, P. M., & Christopoulos, A. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.08.005 · Cited by 65
Self-citationEffects of Guanosine 3',5'-Monophosphate on the Perfused Rat Liver
Exton, J. H., Hardman, J. G., Williams, T. F., Sutherland, E. W., & Park, C. R. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62337-3 · Cited by 64
Whitaker, G. M., Lynn, F. C., McIntosh, C. H. S., & Accili, E. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032675 · Cited by 64
Gault, V. A., Porter, D., Irwin, N., & Flatt, P. R. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0419 · Cited by 64
Coopman, K., Huang, Y., Johnston, N., Bradley, S. J., WILKINSON, G. F., & Willars, G. B. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166009 · Cited by 64
Kumar, S., Pioszak, A., Zhang, C., Swaminathan, K., & Xu, H. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019682 · Cited by 63
Carakushansky, M., Whatmore, A., Clayton, P., Shalet, S. M., Gleeson, H., Price, D., Levine, M. A., & Salvatori, R. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480025 · Cited by 63
Pioszak, A. A., Harikumar, K. G., Parker, N. R., Miller, L. J., & Xu, H. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093138 · Cited by 61
Self-citationRékási, Z., Varga, J. L., Schally, A. V., Halmos, G., Armatis, P. E., Groot, K., & Czömpöly, T. (2000) · Endocrinology · doi:10.1210/endo.141.6.7511 · Cited by 60
Structure–activity relationships for α‐calcitonin gene‐related peptide
Watkins, H. A., Rathbone, D. L., Barwell, J., Hay, D. L., & Poyner, D. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12072 · Cited by 59
Adrenomedullin: Exciting New Horizons
M.Y. Cheung, B., & Tang, F. (2012) · Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · doi:10.2174/187221412799015263 · Cited by 59
Kusano, S., Kukimoto‐Niino, M., Hino, N., Ohsawa, N., Okuda, K., Sakamoto, K., Shirouzu, M., Shindo, T., & Yokoyama, S. (2012) · Protein Science · doi:10.1002/pro.2003 · Cited by 58
Jiang, Y., Cypess, A. M., Muse, E. D., Wu, C.-R., Unson, C. G., Merrifield, R. B., & Sakmar, T. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131200398 · Cited by 58
Why are polar residues within the membrane core evolutionary conserved?
Illergård, K., Kauko, A., & Elofsson, A. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22859 · Cited by 57
Interaction of PTH and PTHrP with Their Receptors
Gardella, T. J., & Ju¨ppner, H. (2000) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1026522619828 · Cited by 57
Role of CGRP-Receptor Component Protein (RCP) in CLR/RAMP Function
Dickerson, I. M. (2013) · Current Protein and Peptide Science · doi:10.2174/13892037113149990057 · Cited by 56
Molecular Mechanisms of Corticotropin-Releasing Factor Receptor-Induced Calcium Signaling
Gutknecht, E., der Linden, I. V., Kolen, K. V., Verhoeven, K. F. C., Vauquelin, G., & Dautzenberg, F. M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050427 · Cited by 54
Investigating G protein signalling bias at the glucagon‐like peptide‐1 receptor in yeast
Weston, C., Poyner, D., Patel, V, Dowell, S., & Ladds, G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12716 · Cited by 53
McDonald, I. M., Austin, C., Buck, I. M., Dunstone, D. J., Gaffen, J. D., Griffin, E. P., Harper, E. A., Hull, R. A. D., Kalindjian, S. B., Linney, I. D., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0707626 · Cited by 53
Willard, F. S., Wootten, D. L., Showalter, A. D., Savage, E. E., FICORILLI, J. V., Farb, T. B., Bokvist, K. B., Alsina‐Fernandez, J., Furness, S. G. B., Christopoulos, A., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080432 · Cited by 53
Self-citationLadds, G., Davis, K., Hillhouse, E. W., & Davey, J. F. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03336.x · Cited by 52
Karteris, E. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1989 · Cited by 52
Lee, L. T. O., Ng, S. Y. L., Chu, J. Y. S., Sekar, R., Harikumar, K. G., Miller, L. J., & Chow, B. K. C. (2014) · The FASEB Journal · doi:10.1096/fj.13-246868 · Cited by 52
Self-citation
Research works printed but not linked: 7
- 10.1124/pr.114.009464 · DOI
- 10.3109/10606820213681 · doi:10.3109/10606820213681 · Paper page
- Yamamoto Y., 2006, Cell Mol. Biol. (Noisy-le-grand), 52, 25
- 10.1124/mol.112.079319 · DOI
- Frohman L. A., 2002, Minerva Endocrinol., 27, 277
- 10.1210/mend.13.12.0391 · doi:10.1210/mend.13.12.0391 · Paper page
- 10.1210/jcem.85.5.6590 · doi:10.1210/jcem.85.5.6590 · Paper page
Cited by
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 724
Self-citationG protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
Metadata
- Authors
- Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M.
- Affiliations
- Monash University (AU)
- Mayo Clinic (US)
- Corresponding author
- Wootten, Denise
- Miller, Laurence J.
- Sexton, Patrick M.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-04-04
- Volume
- 117
- Issue
- 1
- Pages
- 111-138
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2331593504
- Cited by
- 112
- References
- 280
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 7 · 2023: 9 · 2022: 18 · 2021: 10 · 2020: 12 · 2019: 12 · 2018: 17 · 2017: 10 · 2016: 3
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council (1055134, 1061044, 1065410)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- class B G protein-coupled receptors, biased agonism, allosteric site, small molecule drug discovery, peptide hormones, osteoporosis, type 2 diabetes, obesity, drug development
- MeSH terms
- Allosteric Regulation, Structure-Activity Relationship, Dimerization, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.